Delayed Cleansing Notice
Released
Released
Announcement PDF
ASX ANNOUNCEMENT
ASX: HIQ
HITIQ LTD 4/38-42 White Street, South Melbourne, VIC 3205
ACN 609 543 213 investors@hitiq.com
hitiq.com
24 February 2026
Delayed Cleansing Notice
HITIQ Limited (ASX: HIQ) (HITIQ or the Company) advises, further to its trading halt request dated
20 February 2026, that, due to an administrative oversight, the Company failed to lodge a cleansing
notice under section 708A of the Corporations Act 2001 (Cth) (Corporations Act) within the
prescribed 5 business day period following the issue of shares issued on 19 January 2026 (the
Shares).
The Company has investigated the matter and determined that none of the Shares have been
offered for sale, or have been sold, in technical breach of section 707 of the Corporations Act.
Each party who was issued the Shares has now agreed to enter into an agreement for the voluntary
escrow of the Shares for a period of the shorter of 12 months from the date the shares were issued,
or until the Company releases a cleansing prospectus. Following its investigations, the Company
confirms that there was no cleansing issue in respect of HIQOA listed options.
However, the Company has become aware of an issue in respect of section 723(3) of the
Corporations Act in regard to the issue of HIQOA listed options on 22 December 2025. Pursuant to
section 723(3)(b) and 724(1)(b)(ii) of the Corporations Act, securities issued under a prospectus
are required to be admitted to quotation within 3 months after the date of the prospectus
(Quotation Period). The Company lodged a rights issue prospectus on 15 May 2025 (the
Prospectus), meaning all securities proposed to be quoted under the Prospectus were required to
be admitted to quotation by 15 August 2025.
All quoted securities offered under the Prospectus were admitted to quotation during the
Quotation Period other than 16,135,199 HIQOA Options to GBA Capital Pty Ltd as the underwriter
to the rights issue and 6,181,818 HIQOA Options to GBA Capital Pty Ltd and SP Corporate Advisory
Pty Ltd as joint lead managers to the rights issue (together, the Advisor Securities), which were
issued on 22 December 2025. Whilst confirmation has been received that all securities issued
under the Prospectus were quoted by the ASX, the Advisor Securities were not admitted for
quotation within the Quotation Period.
The effect of the Advisor Securities not being admitted to quotation within the Quotation Period
is that the issue of all Advisor Securities under the Prospectus are deemed void and the Company
is obliged to return all subscription funds to the applicants for the Options previously issued, unless
it obtains a relevant Court order extending the Quotation Period.
The Company intends to submit an application to the Court seeking orders to rectify the issue. The
Company will request for voluntary suspension in respect of the HIQOA listed options while the
matter is resolved.
HITIQ LTD 4/38-42 White Street, South Melbourne, VIC 3205
ACN 609 543 213 investors@hitiq.com
hitiq.com
The release of this announcement was authorised by the Board.
– END –
About HITIQ
HITIQ Limited (ASX: HIQ) develops concussion management and athlete safety technology for sport,
clinical, and research applications worldwide. The company combines smart mouthguards and analytics
platforms to deliver data-driven safety solutions.
Authorised for release by the Board of HITIQ Limited
To learn more about this announcement please visit the HITIQ Investor Hub by clicking HERE
Forward-Looking Statements Disclaimer
This announcement may contain forward-looking statements. Such statements involve known and unknown
risks, uncertainties, and other factors that may cause actual outcomes to differ materially. HITIQ does not
undertake any obligation to update forward-looking statements, except as required by law.
Share your feedback
Discover